Burundi vs Papua New Guinea: HIV/AIDS deaths averted by antiretroviral therapy
HIV/AIDS deaths averted by antiretroviral therapy over time
- Burundi
- Papua New Guinea
How they compare
Burundi currently reports 4,624 deaths against 4,270 deaths in Papua New Guinea, a difference of 354 deaths.
That makes Burundi's figure about 1.1 times Papua New Guinea's.
The two have swapped places 1 time across 35 shared years of data; in 1990 it was Papua New Guinea ahead.
Burundi ranks 39th and Papua New Guinea ranks 42nd of 157 countries.
Burundi has averaged higher in every one of the 4 decades both report.
Head to head by decade
| Decade | Burundi | Papua New Guinea | Difference | Ahead |
|---|---|---|---|---|
| 1990s | 0 deaths | 0 deaths | 0 deaths | — |
| 2000s | 1,207 deaths | 348.4 deaths | 859 deaths | Burundi |
| 2010s | 4,004 deaths | 2,272 deaths | 1,731 deaths | Burundi |
| 2020s | 4,704 deaths | 3,623 deaths | 1,081 deaths | Burundi |
Averages of every year both report within each decade.
Frequently asked questions
- Which has higher hiv/aids deaths averted by antiretroviral therapy, Burundi or Papua New Guinea?
- Burundi, at 4,624 deaths against 4,270 deaths in Papua New Guinea as of 2024.
- What is the difference in hiv/aids deaths averted by antiretroviral therapy between Burundi and Papua New Guinea?
- 354 deaths, with Burundi ahead.
- How many years of comparable data are there for Burundi and Papua New Guinea?
- 35 years are reported by both, from 1990 to 2024.
- How do Burundi and Papua New Guinea rank globally for hiv/aids deaths averted by antiretroviral therapy?
- Burundi ranks 39th and Papua New Guinea ranks 42nd of 157 countries.
- Where does this data come from?
- Joint United Nations Programme on HIV/AIDS (2026) – with minor processing by Our World in Data, published as HIV/AIDS deaths averted by antiretroviral therapy. Statizoid refreshes it automatically from the source and publishes the full history for both places.
Individual pages
About this data
Number of deaths prevented as a direct result of Antiretroviral Therapy (ART) among people living with HIV. It is calculated by comparing the observed mortality rates in individuals receiving ART to the estimated mortality rates in the absence of such treatment. This is the central estimate.